Regulatory Toxicology and Pharmacology
|
Abbreviated title (ISO 4)
|
Regul. Toxicol. Pharmacol. |
|---|---|
| Discipline | Toxicology and Pharmacology |
| Language | English |
| Edited by | Gio B. Gori |
| Publication details | |
| Publisher |
Elsevier on behalf of the International Society of Toxicology & Pharmacology
|
|
Publication history
|
1981–present |
| Frequency | Monthly |
| 2.031 | |
| Indexing | |
| ISSN | 0273-2300 |
| LCCN | 81646304 |
| CODEN | RTOPDW |
| OCLC no. | 485750423 |
| Links | |
Regulatory Toxicology and Pharmacology is a monthly peer-reviewed scientific journal which covers legal aspects of toxicological and pharmacological regulations. It is published by Elsevier on behalf of the International Society of Regulatory Toxicology & Pharmacology. The current editor-in-chief is Gio Batta Gori. The journal is financed in part by the tobacco, pharmaceutical, and chemical industries.[1]
In 2002, a group of 45 academics wrote a letter accusing the journal of a concealed pro-industry bias, saying that it "reads like an industry trade publication, but it's masked as a peer-reviewed journal" and that it lacked any "credible peer-review process". The scientists criticized the journal for failing to disclose conflicts of interest on the part of article authors and editors, citing a case in which Gori was paid $30,000 by the Tobacco Institute to publish an article in the journal dismissing the health risks of secondhand smoke.[2]
The journal has been accused of being "broker of junk science" by the Center for Public Integrity.[3]
Abstracting and indexing
The journal is abstracted and indexed in EMBASE, EMBiology, and Scopus.
According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.031, ranking it 56th out of 87 journals in the category "Toxicology"[4] and 146th out of 254 journals in the category "Pharmacology & Pharmacy".[5]
